(NYSE: TMO) Thermo Fisher Scientific's forecast annual revenue growth rate of 5.37% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 7.48%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.56%.
Thermo Fisher Scientific's revenue in 2025 is $42,370,000,000.On average, 7 Wall Street analysts forecast TMO's revenue for 2025 to be $16,791,788,408,519, with the lowest TMO revenue forecast at $16,747,474,222,817, and the highest TMO revenue forecast at $16,866,731,685,440. On average, 8 Wall Street analysts forecast TMO's revenue for 2026 to be $17,928,443,408,504, with the lowest TMO revenue forecast at $17,673,807,244,590, and the highest TMO revenue forecast at $18,141,364,093,518.
In 2027, TMO is forecast to generate $19,364,916,651,207 in revenue, with the lowest revenue forecast at $19,238,954,723,940 and the highest revenue forecast at $19,490,878,578,475.